Who benefits from radiotherapy in treatment of endometrial cancer and at what price?
- 1 April 2000
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 355 (9213) , 1381-1382
- https://doi.org/10.1016/s0140-6736(00)02131-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The Use of Adjuvant Radiation Therapy by Members of the Society of Gynecologic OncologistsGynecologic Oncology, 1999
- A Comparison of Treatment Strategies for Endometrial Adenocarcinoma: Analysis of Financial ImpactGynecologic Oncology, 1999
- Postoperative radiotherapy for endometrial carcinoma stage I. Wide variation in referral patterns but no effect on long-term survival in a retrospective study in the southeast NetherlandsEuropean Journal Of Cancer, 1998
- Stage I corpus cancer: Is teletherapy necessary?American Journal of Obstetrics and Gynecology, 1997
- The Practice of Surgical Staging and Its Impact on Adjuvant Treatment Recommendations in Patients with Stage I Endometrial CarcinomaGynecologic Oncology, 1996
- Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancerInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in Stage I endometrial cancer: A comparison of complication ratesGynecologic Oncology, 1990
- Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factorsInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Risk factors and recurrent patterns in Stage I endometrial cancerAmerican Journal of Obstetrics and Gynecology, 1985